Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Jun;22(6):779-87.
doi: 10.1177/2047487314533622. Epub 2014 Apr 16.

Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study

Affiliations
Comparative Study

Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study

Suzanne V Arnold et al. Eur J Prev Cardiol. 2015 Jun.

Abstract

Aims: While patients with diabetes mellitus (DM) have more extensive coronary disease and worse survival after acute myocardial infarction (AMI) than patients without DM, data on whether they experience more angina are conflicting.

Methods: We examined angina prevalence over the year following AMI among 3367 patients, including 1080 (32%) with DM, from 24 US hospitals enrolled in the TRIUMPH registry from 2005 to 2008.

Results: Patients with vs. without DM were more likely to be treated with antianginal medications both at discharge and over follow up. Despite more aggressive angina therapy, patients with vs. without DM had higher prevalence and severity of angina prior to AMI (49 vs. 43%, p = 0.001) and at each follow-up assessment, although rates of angina declined in both groups over time. In a hierarchical, multivariable, repeated-measures model that adjusted for multiple demographic and clinical factors including severity of coronary disease and in-hospital revascularization, DM was associated with a greater odds of angina over the 12 months of follow up; this association increased in magnitude over time (12-month OR 1.18, 95% CI 1.01-1.37; DM*time pinteraction = 0.008).

Conclusions: Contrary to conventional wisdom, angina is more prevalent and more severe among patients with DM, both prior to and following AMI. This effect is amplified over time and independent of patient and treatment factors, including the presence of multivessel disease and coronary revascularization. This increased burden of angina may be due to more diffuse nature of coronary disease, more rapid progression of coronary disease over time, or greater myocardial demand among DM patients.

Keywords: Angina; diabetes mellitus; myocardial infarction.

PubMed Disclaimer

Conflict of interest statement

The other authors report no conflicts of interest.

Figures

Figure 1
Figure 1. Percentage of Patients Reporting Angina Prior to and after Myocardial Infarction
The red line indicates the percentage of patients with DM who reported any angina (SAQ angina frequency score <100), and the blue line represents the percentage of patients without DM who reported angina at each time point.
Figure 2
Figure 2. Percentage of Patients Reporting Different Levels of Angina Four weeks Prior to, and 1, 6, and 12 months after Myocardial Infarction
As assessed with the Seattle Angina Questionnaire angina frequency domain. Scores 0–30 indicate daily angina; 31–60 indicate weekly angina; 61–99 indicate monthly angina; 100 indicates no angina. p<0.01 for comparisons between groups at all time points.
Figure 3
Figure 3. Relative Risk of Angina among Patients with Diabetes over the Year Following Myocardial Infarction
Reference group is patients without diabetes. Adjusted for age, sex, race, hypertension, smoking status, depressive symptoms, prior angioplasty, prior bypass graft surgery, in-hospital angioplasty, in-hospital bypass graft surgery, presence of multivessel disease, left ventricular dysfunction, ST-elevations on presentation, and GRACE discharge score

Similar articles

Cited by

References

    1. Stolker JM, Sun D, Conaway DG, Jones PG, Masoudi FA, Peterson PN, Krumholz HM, Kosiborod M, Spertus JA. Importance of measuring glycosylated hemoglobin in patients with myocardial infarction and known diabetes mellitus. Am J Cardiol. 2010;105(8):1090–4. - PMC - PubMed
    1. Abi Khalil C, Roussel R, Mohammedi K, Danchin N, Marre M. Cause-specific mortality in diabetes: recent changes in trend mortality. Eur J Prev Cardiol. 2012;19(3):374–81. - PubMed
    1. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EM. Diabetes and mortality following acute coronary syndromes. JAMA. 2007;298(7):765–75. - PubMed
    1. Duarte R, Castela S, Reis RP, Correia MJ, Ramos A, Pereira AP, Martins P, Correia JM. Acute coronary syndrome in a diabetic population--risk factors and clinical and angiographic characteristics. Rev Port Cardiol. 2003;22(9):1077–88. - PubMed
    1. Herlitz J, Wognsen GB, Emanuelsson H, Haglid M, Karlson BW, Karlsson T, Albertsson P, Westberg S. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care. 1996;19(7):698–703. - PubMed

Publication types

MeSH terms